\n'); // -->
個股合併月營收-4109
��撅祉𤩎璆�
�砍虬鈭鍦��
��閙�见𥼚撠�
�贝�⊿�蠘汗
�贝�∠蜇閬�
�祇�贝牧��擧㮾
�砍虬璆剖�嗵����
撣��聦�����
�𤩎�啹璁�瘜�
��𠉛䔄��瘜�
��匧⏚銝滚⏚��删��
����閰蓥摯�𥼚���
鋆𨅯���号�蠧鈭钅�
�贝�⊥�磰�
�抅�𧋦�𢒰
�∪�寡”�𣶹
�抅�𧋦�����
�抅�𧋦鞈���
�⊥𧋦敶X��
�∪⏚�錇蝑�
蝬梶�毺蜀���
�㬢�⏚�賢��
頧㗇�閗��
���𤣰�����
��滚之銵䔶�𧢲�
�𤩎�啹蝯����
�㮾��𨀣�𡃏��
蝐𣬚Ⅳ�����
蝐𣬚Ⅳ��雿�
�𪆓�𧙗����
�𪆓�𧙗鞈芾身
瘜蓥犖����
��靽嘥澈摮�
��滩���滚�
銝餃�偦�脣枂
��蓥縑����
鞎∪�坔����
鞈�𤩎鞎惩�萇陛銵�
鞈�𤩎鞎惩�萄迤銵�
鞈�𤩎鞎惩�菔”撟渲”
��滨�𠰴迤銵�
��滨�𠰴僑銵�
鞎∪�蹱�𠉛��迤銵�
鞎∪�蹱�𠉛��僑銵�
�𣶹��烐���讛”
��銵枏����
嚗怎�𡁜��
���孵��
����韏啣𨋍���
加捷生醫(4109)
月營收
季盈餘
2025/03/01
19.05元 (加捷生醫股價)
2025/03/01
19.27% (年增率)
70百萬元 (營收)
加捷生醫(4109) 年度營收走勢圖
加捷生醫(4109)月營收明細
單位:仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
70,235
127.00%
58,889
19.27%
132,736
-16.91%
114/02
30,941
-1.96%
57,583
-46.27%
62,501
-38.03%
114/01
31,560
-48.41%
43,282
-27.08%
31,560
-27.08%
113/12
61,172
82.95%
24,751
147.15%
535,653
60.94%
113/11
33,436
-2.58%
34,204
-2.25%
474,481
54.01%
113/10
34,320
13.47%
25,648
33.81%
441,045
61.04%
113/09
30,246
-10.00%
25,680
17.78%
406,725
63.85%
113/08
33,606
9.94%
27,839
20.72%
376,479
69.16%
113/07
30,568
-57.46%
29,365
4.10%
342,873
76.09%
113/06
71,861
61.52%
27,997
156.67%
312,305
88.88%
113/05
44,491
22.91%
29,340
51.64%
240,444
75.06%
113/04
36,199
-38.53%
30,128
20.15%
195,953
81.42%
113/03
58,889
2.27%
31,823
85.05%
159,754
105.12%
113/02
57,583
33.04%
21,339
169.85%
100,865
118.99%
113/01
43,282
74.87%
24,721
75.08%
43,282
75.08%
112/12
24,751
-27.64%
32,500
-23.84%
332,835
5.83%
112/11
34,204
33.36%
24,171
41.51%
308,084
9.25%
112/10
25,648
-0.12%
27,447
-6.55%
273,880
6.22%
112/09
25,680
-7.76%
23,929
7.32%
248,232
7.74%
112/08
27,839
-5.20%
34,087
-18.33%
222,552
7.79%
112/07
29,365
4.89%
26,589
10.44%
194,713
12.96%
112/06
27,997
-4.58%
21,504
30.19%
165,348
13.42%
112/05
29,340
-2.62%
26,920
8.99%
137,351
10.51%
112/04
30,128
-5.33%
21,115
42.69%
108,011
10.94%
112/03
31,823
49.13%
26,284
21.07%
77,883
2.14%
112/02
21,339
-13.68%
21,826
-2.23%
46,060
-7.82%
112/01
24,721
-23.94%
28,139
-12.15%
24,721
-12.15%
111/12
32,500
34.46%
33,760
-3.73%
314,511
29.92%
111/11
24,171
-11.94%
21,326
13.34%
282,011
35.37%
111/10
27,447
14.70%
25,191
8.96%
257,840
37.89%
111/09
23,929
-29.80%
17,872
33.89%
230,393
42.39%
111/08
34,087
28.20%
21,724
56.91%
206,464
43.44%
111/07
26,589
23.65%
16,335
62.77%
172,377
41.05%
111/06
21,504
-20.12%
16,558
29.87%
145,788
37.70%
111/05
26,920
27.49%
17,674
52.31%
124,284
39.15%
111/04
21,115
-19.67%
17,234
22.52%
97,364
35.90%
111/03
26,284
20.43%
19,665
33.66%
76,249
40.14%
111/02
21,826
-22.44%
49,965
111/01
28,139
-16.65%
28,139
110/12
33,760
58.30%
242,082
110/11
21,326
-15.34%
208,322
110/10
25,191
40.95%
186,996
110/09
17,872
-17.73%
161,805
110/08
21,724
32.99%
143,933
110/07
16,335
-1.35%
122,209
110/06
16,558
-6.31%
105,874
110/05
17,674
2.55%
89,316
110/04
17,234
-12.36%
71,642
說明:自2013年起上市櫃公司因IFRSs會計準則規範,每月公告的營收必須是合併營收,不再公告非合併營收。2012年(含)前,合併營收是採自願公告。